AH Apotex Health Corp. Stock: price and management transactions · Canada · SEDISource id SEDI:apotex-health-corp CA · SEDI Follow the Apotex Health Corp. stock price and the full insider trade history of the company, a listed equity based in Canada. Shares are quoted on the CA market, under the oversight of SEDI. The latest transaction was disclosed on 18 September 2026 (15 - Acquisition or disposition under a prospectus). Among the most active insiders: Oberman, Allan Grant. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 September 2026
All Executives89 Thresholds0 Prospectus0 Other0
Declarations 89 total
▲ 3 - 10% Security Holder of Issuer · Executives · 18 Sept 2026
5,215,929 shares @ CA$34.00 Common Shares SEDI:4779481 Canonical exit: 17 Dec 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 18 Sept 2026
532,062 shares @ CA$34.00 99.9% of flow Common Shares SEDI:4779329 Canonical exit: 17 Dec 2026 (T+90) ● 4 - Director of Issuer · Executives · 18 Sept 2026
532,062 shares @ CA$0.01 0.0% of flow Common Shares SEDI:4779328 ● 4 - Director of Issuer · Executives · 9 Jun 2026
Common Shares SEDI:4779327 ● 4 - Director of Issuer · Executives · 18 Sept 2026
532,062 shares @ CA$0.01 0.0% of flow Restricted Share Units SEDI:4779326 ▲ 3 - 10% Security Holder of Issuer · Executives · 18 Sept 2026
19,252,009 shares @ CA$34.00 100.0% of flow Common Shares SEDI:4779304 Canonical exit: 17 Dec 2026 (T+90) ● 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 13 Aug 2026
136,158 shares Restricted Share Units SEDI:4766174 ● 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
112,682 shares Restricted Share Units SEDI:4766171 ◇ 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
338,046 shares Options SEDI:4766170 ● 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
9,557 shares Restricted Share Units SEDI:4766169 ◇ 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
28,671 shares Options SEDI:4766167 ● 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
12,228 shares Restricted Share Units SEDI:4766166 ◇ 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
36,684 shares Options SEDI:4766165 ● 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
12,406 shares Restricted Share Units SEDI:4766162 ◇ 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
37,218 shares Options SEDI:4766160 ● 4 - Director of Issuer · Executives · 1 Jul 2026
5,828 shares Deferred Share Units SEDI:4766159 ● 4 - Director of Issuer · Executives · 9 Jun 2026
Deferred Share Units SEDI:4766158 ● 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
20,205 shares Restricted Share Units SEDI:4766157 ◇ 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
60,615 shares Options SEDI:4766154 ● 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
12,840 shares Restricted Share Units SEDI:4766118 ◇ 5 - Senior Officer of Issuer · Executives · 1 Jul 2026
38,520 shares Options SEDI:4766117 ● 5 - Senior Officer of Issuer · Executives · 9 Jun 2026
● 4 - Director of Issuer · Executives · 1 Jul 2026
3,846 shares Deferred Share Units SEDI:4766114 ● 4 - Director of Issuer · Executives · 9 Jun 2026
Deferred Share Units SEDI:4766113 ● 4 - Director of Issuer · Executives · 1 Jul 2026
3,846 shares Deferred Share Units SEDI:4766112 25 of 89 declarations
Load more (64 remaining) About Apotex Health Corp. Apotex Health Corp. is a Canadian pharmaceutical company that specializes in the manufacturing of generic drugs. It is listed on the Toronto Stock Exchange under the symbol XTSE.